Grants paid by Potts Memorial Foundation
EIN 14-1347714 · Hudson, NY · Form 990-PF, Part XV
Potts Memorial Foundation of Hudson, NY (EIN 14-1347714) reported 57 grants paid totaling $2,034,456 to 25 recipients in tax years 2018–2025, on Form 990-PF, Part XV. Derived from IRS e-file data, dataset version 2026.09.0, built 2026-09-03.
Grants paid
$2,034,456
57 grants
Recipients
25
distinct organizations
Tax years
2018–2025
8 filings in the corpus
By tax year
| Tax year | Grants paid | Amount paid | Approved for future |
|---|---|---|---|
| 2018 | 8 | $249,182 | — |
| 2019 | 7 | $260,986 | — |
| 2020 | 6 | $261,000 | — |
| 2021 | 7 | $256,381 | — |
| 2022 | 6 | $237,875 | — |
| 2023 | 6 | $212,310 | — |
| 2024 | 8 | $263,722 | — |
| 2025 | 9 | $293,000 | — |
Top recipients
The 25 recipients receiving the most from Potts Memorial Foundation, by grants paid, out of 25 distinct recipients.
| Recipient | Match | Location | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Weill Cornell Medical College | U | New York, NY | 8 | $387,006 | 2025 |
| The Rockefeller University 13-1624158 | B | New York, NY | 6 | $275,000 | 2025 |
| Trudeau Institute 14-1401413 | B | Saranac Lake, NY | 4 | $130,000 | 2025 |
| Albert Einstein College of Medicine 83-0621846 | B | Bronx, NY | 3 | $125,000 | 2022 |
| Washington University School of Medicine | U | St Louis, MO | 3 | $102,000 | 2025 |
| National Jewish Health 74-2044647 | B | Denver, CO | 3 | $87,000 | 2021 |
| Health Research Inc | U | Menands, NY | 3 | $83,075 | 2024 |
| Trustees of Tufts University | U | Boston, MA | 2 | $80,000 | 2025 |
| Rutgers Nj Medical School Public Health Research Institute | U | Newark, NJ | 2 | $72,560 | 2023 |
| Johns Hopkins University School of Medicine | U | Baltimore, MD | 3 | $70,000 | 2025 |
| Weill Cornell Medicine Dept of Microbiology & Immunology | U | New York, NY | 1 | $70,000 | 2020 |
| Columbia Memorial Health Foundation 14-1761112 | B | Hudson, NY | 4 | $67,500 | 2023 |
| Weill Cornell Medical | U | New York, NY | 2 | $60,000 | 2018 |
| Trustees of Columbia University 13-5598093 | C | New York, NY | 2 | $56,702 | 2025 |
| University of Georgia 58-6043703 | B | Athens, GA | 1 | $50,000 | 2022 |
| Weill Cornell Medicine NY Presbyterian Div of Infectious Disease | U | New York, NY | 1 | $50,000 | 2020 |
| Johns Hopkins Medicine | U | Baltimore, MD | 1 | $48,432 | 2018 |
| University of North Carolina 56-6001394 | C | Chapel Hill, NC | 1 | $40,000 | 2019 |
| Albany Medical College Dept of Immunology & Microbial Disease | U | Albany, NY | 1 | $33,000 | 2022 |
| Worcester Polytechnic Institute | U | Worcester, MA | 1 | $30,000 | 2024 |
| Umass Chan Medical School 04-3108190 | C | Worcester, MA | 1 | $25,000 | 2025 |
| Nyu Grossman Medicine | U | New York, NY | 1 | $25,000 | 2023 |
| Chapman University School of Pharmacy | U | Irvine, CA | 1 | $25,000 | 2020 |
| Columbia University 82-2244803 | C | New York, NY | 1 | $22,500 | 2019 |
| Tufts Univ School of Medicine | U | Boston, MA | 1 | $19,681 | 2019 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Every grant
All 57 grant rows this organization reported, most recent first.
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Trustees of Tufts University Boston, MA | U | $50,000 | paid | RESEARCH UNDERSTANDING REGULATION OF CALCIUM-MEDIATED EFFECTS ON MYCOBACTERIUM TUBERCULOSIS GROWTH. | 202641289349100719 |
| 2025 | The Rockefeller University New York, NY | B | $50,000 | paid | RESEARCH PEBBLE: SUSTAINING AND EXPANDING A CRITICAL RESOURCE FOR CRISPR-BASED FUNCTIONAL GENOMICS IN MYCOBACTERIA | 202641289349100719 |
| 2025 | Weill Cornell Medical College New York, NY | U | $37,000 | paid | RESEARCH GENIC NETWORKS THAT PREVENT KILLING OF MYCOBACTERIUM TUBERCULOSIS BY ATP SYNTHASE INHIBITORS | 202641289349100719 |
| 2025 | Trustees of Columbia University New York, NY | C | $36,000 | paid | RESEARCH EARLY HOST BIOMARKERS OF CLINICAL OUTCOMES IN MDR-TB AND HIV CO-INFECTION USING OLINK PROTEOMICS | 202641289349100719 |
| 2025 | Johns Hopkins University School of Medicine Baltimore, MD | U | $25,000 | paid | RESEARCHING THE ELIMINATION OF SENESCENT CELLS WITH SENOLYTIC HOST-DIRECTED THERAPY REDUCES TUBERCULOSIS PROGRESSION IN SUSCEPTIBLE MOUSE MODELS. | 202641289349100719 |
| 2025 | Washington University School of Medicine St Louis, MO | U | $25,000 | paid | RESEARCH THE NONCANONICAL AND RAPID IFN-1 INDUCTION BY NEUTROPHILS IN RESPONSE TO MYCOBACTERIUM TUBERCULOSIS. | 202641289349100719 |
| 2025 | Trudeau Institute Saranac Lake, NY | B | $25,000 | paid | SUPPORT THE NORTHEAST REGIONAL WORLD TB DAY CONFERENCE. | 202641289349100719 |
| 2025 | Umass Chan Medical School Worcester, MA | C | $25,000 | paid | RESEARCH UNDERSTANDING THE ROLE OF HIGH-FREQUENCY GENETIC VARIATION IN TUBERCULOSIS TREATMENT FAILURE | 202641289349100719 |
| 2025 | Weill Cornell Medical College New York, NY | U | $20,000 | paid | RESEARCH OF POST-TUBERCULOSIS LUNG DISEASE IN PEOPLE LIVING WITH HIV: MATRIX METALLOPROTEINASES AND THE AGE-RAGE AXIS | 202641289349100719 |
| 2024 | Weill Cornell Medical College New York, NY | U | $60,000 | paid | POST DOC FELLOWSHIP FOR TB RESEARCH | 202501269349100315 |
| 2024 | Weill Cornell Medical College New York, NY | U | $52,500 | paid | STIPEND FOR TB RESEARCH | 202501269349100315 |
| 2024 | Trustees of Tufts University Boston, MA | U | $30,000 | paid | EXPLORING THE ROLE OF CALCIUM HOMEOSTASIS IN MTB | 202501269349100315 |
| 2024 | Worcester Polytechnic Institute Worcester, MA | U | $30,000 | paid | THE ROLE OF TRPG IN ARTEMISININ ACTIVITY | 202501269349100315 |
| 2024 | Trudeau Institute Saranac Lake, NY | B | $30,000 | paid | TARGET VALIDATION AND PHARMACOKINETIC EVALUATION OF RAPIDLY TUBERCULOCIDAL COMPOUNDS | 202501269349100315 |
| 2024 | Johns Hopkins University School of Medicine Baltimore, MD | U | $25,000 | paid | RNA SENSOR LGP2 AND ITS ROLE DURING TB INFECTION | 202501269349100315 |
| 2024 | Trustees of Columbia University New York, NY | C | $20,702 | paid | USE OF XPERT MTB/RIF ULTRA AND NOVEL HIGH DIMENSIONAL PROTEOMICS... | 202501269349100315 |
| 2024 | Health Research Inc Menands, NY | U | $15,520 | paid | WORLD TB DAY SUPPORT | 202501269349100315 |
| 2023 | Weill Cornell Medical College New York, NY | U | $50,000 | paid | INSIGHTS INTO THE TRANSMISSION BIOLOGY OF M. TUBERCULOSIS | 202411319349100611 |
| 2023 | Rutgers Nj Medical School Public Health Research Institute Newark, NJ | U | $47,560 | paid | INVESTIGATION OF IMMUNE MECHANISMS REGULATING HETEROGENEITY | 202411319349100611 |
| 2023 | Weill Cornell Medical College New York, NY | U | $46,250 | paid | STUDYING THE ROLE OF MACROPHAGES AND GLUCONEOGENESIS IN THE REGULATION OF MYCOBACTERIUM TUBERCULOSIS PERSISTENCE IN A MOUSE MODEL OF LATENCY | 202411319349100611 |
| 2023 | Nyu Grossman Medicine New York, NY | U | $25,000 | paid | WORLD TUBERCULOSIS DAY SUPPORT | 202411319349100611 |
| 2023 | Trudeau Institute Saranac Lake, NY | B | $25,000 | paid | IN VIVO VALIDATION OF A NOVEL MYCOBACTERIUM TUBERCULOSIS DRUG TARGET, ASPC | 202411319349100611 |
| 2023 | Columbia Memorial Health Foundation Hudson, NY | B | $18,500 | paid | TO PURCHASE A HAMILTON-C1 PORTABLE VENTILATOR | 202411319349100611 |
| 2022 | Weill Cornell Medical College New York, NY | U | $61,875 | paid | STUDYING THE ROLE OF MACROPHAGES AND GLUCONEOGENESIS IN THE REGULATION OF MYCOBACTERIUM TUBERCULOSIS PERSISTENCE IN A MOUSE MODEL OF LATENCY | 202321239349100617 |
| 2022 | University of Georgia Athens, GA | B | $50,000 | paid | "EVALUATION OF THE ROLE OF MYELOID-DERIVED SUPPRESSOR CELLS IN THE IMMUNE RESPONSE TO MYCOBACTERIUM TUBERCULOSIS" | 202321239349100617 |
| 2022 | Albert Einstein College of Medicine Bronx, NY | B | $50,000 | paid | SUPPORTING "PDIM OF M. TUBERCULOSIS NEW SOLUTIONS TO PERSISTENT PROBLEM" | 202321239349100617 |
| 2022 | Albany Medical College Dept of Immunology & Microbial Disease Albany, NY | U | $33,000 | paid | SECRETION MECHANISM OF C-DI-AMP BY MYCOBACTERIUM TUBERCULOSIS AND THE IMPACT ON EFFICACY OF THE BCG VACCINE | 202321239349100617 |
| 2022 | Rutgers Nj Medical School Public Health Research Institute Newark, NJ | U | $25,000 | paid | SUPPORTING WORLD TUBERCULOSIS DAY ON 3/23/23 | 202321239349100617 |
| 2022 | Columbia Memorial Health Foundation Hudson, NY | B | $18,000 | paid | SUPPORTING THE "ADVANCING THE WORKFORCE" EDUCATION FUND FOR CERTIFIED RESPIRATORY THERAPISTS. | 202321239349100617 |
| 2021 | Weill Cornell Medical College New York, NY | U | $59,381 | paid | STUDYING THE ROLE OF MACROPHAGES AND GLUCONEOGENESIS IN THE REGULATION OF MYCOBACTERIUM TUBERCULOSIS PERSISTENCE IN A MOUSE MODEL OF LATENCY | 202211259349101656 |
| 2021 | Albert Einstein College of Medicine Bronx, NY | B | $50,000 | paid | MYCOBACTERIUM TUBERCULOSIS ANTIBIOTIC PERSISTENCE THROUGH HIBERNATION | 202211259349101656 |
| 2021 | Trudeau Institute Saranac Lake, NY | B | $50,000 | paid | ROLE OF HEME SYNTHETIC ENZYME, COPROHEME DECARBOXYLASE IN COORDINATING HEME SYNTHESIS AND UPTAKE IN RESPONSE TO IRON AVAILABILITY IN MYCOBACTERIUM TUBERCULOSIS | 202211259349101656 |
| 2021 | National Jewish Health Denver, CO | B | $37,000 | paid | DO GLUCOCORTICOIDS ENHANCE MACROPHAGE CONTROL OF MYCOBACTERIUM TUBERCULOSIS? | 202211259349101656 |
| 2021 | The Rockefeller University New York, NY | B | $25,000 | paid | TOWARDS RESEARCH ON THE GENETIC BASIS FOR PERSISTENT TUBERCULOSIS INFECTION | 202211259349101656 |
| 2021 | Johns Hopkins University School of Medicine Baltimore, MD | U | $20,000 | paid | ENHANCING THE IMMUNOGENICITY OF A THERAPEUTIC DNA VACCINE TARGETING THE M. TUBERCULOSIS PERSISTOR RELMTB | 202211259349101656 |
| 2021 | Columbia Memorial Health Foundation Hudson, NY | B | $15,000 | paid | TOWARD THE PURCHASE OF TWO HAMILTON-C-1 VENTILATORS | 202211259349101656 |
| 2020 | Weill Cornell Medicine Dept of Microbiology & Immunology New York, NY | U | $70,000 | paid | UNDERSTANDING TRANSMISSION BIOLOGY OF MTB | 202101349349102925 |
| 2020 | The Rockefeller University New York, NY | B | $50,000 | paid | MECHANISTIC BASIS OF M+RAB CONTROL OF INTRINSIC DRUG RESISTANCE | 202101349349102925 |
| 2020 | The Rockefeller University New York, NY | B | $50,000 | paid | MYCRISPR: A WEB PORTAL FOR DESIGNING & ANALYZING CRISPR BASED GENOMIC EXPERIMENTS | 202101349349102925 |
| 2020 | Weill Cornell Medicine NY Presbyterian Div of Infectious Disease New York, NY | U | $50,000 | paid | NATURAL KILLER CELLS IN CONTROL OF MTB INFECTION | 202101349349102925 |
| 2020 | Chapman University School of Pharmacy Irvine, CA | U | $25,000 | paid | AMPHIPATHIC MACROCYCLIC PEPTIDE AGAINST NON TB MYCOBACTERIA | 202101349349102925 |
| 2020 | Columbia Memorial Health Foundation Hudson, NY | B | $16,000 | paid | FOR PURCHASE OF NEGATIVE AIR PRESSURE UNITS | 202101349349102925 |
| 2019 | Health Research Inc Menands, NY | U | $53,805 | paid | CHARACTERIZING STRUCTURE OF NOVEL TRANSCRIPTION FACTOR AbMr | 202001349349100045 |
| 2019 | The Rockefeller University New York, NY | B | $50,000 | paid | GENOMIC APPROACH TO IDENTIFY INTRINSIC DRUG RESISTANCE IN MYCOB TB | 202001349349100045 |
| 2019 | The Rockefeller University New York, NY | B | $50,000 | paid | MyCRISPR: A WEB PORTAL | 202001349349100045 |
| 2019 | University of North Carolina Chapel Hill, NC | C | $40,000 | paid | TREATMENT FOR PERSISTENT TB | 202001349349100045 |
| 2019 | National Jewish Health Denver, CO | B | $25,000 | paid | COMPUTATIONAL ANALYSIS OF GENETIC & STRUCTURAL VARIATION IMPACTING DRUG EFFICACY | 202001349349100045 |
| 2019 | Columbia University New York, NY | C | $22,500 | paid | LEVERAGING NOVEL MOLECULAR DIAGNOSTICS- UGANDA | 202001349349100045 |
| 2019 | Tufts Univ School of Medicine Boston, MA | U | $19,681 | paid | WORLD TB DAY - BOSTON MA | 202001349349100045 |
| 2018 | Washington Univ School of Medicine St Louis, MO | U | $52,000 | paid | HOST FATTY OXIDATION MYCOBACTERIUM TB PATHOGENESIS | 201941339349103344 |
| 2018 | Johns Hopkins Medicine Baltimore, MD | U | $48,432 | paid | RU2224C MYCOBACTERIUYM TB | 201941339349103344 |
| 2018 | Weill Cornell Medical New York, NY | U | $30,000 | paid | PERSISTERS & POLYPHOSOPHATE ANTIBIOTIC TOLERANCE | 201941339349103344 |
| 2018 | Weill Cornell Medical New York, NY | U | $30,000 | paid | ESSENTIALITY OF ASPARTE MYCOBACTERIUM | 201941339349103344 |
| 2018 | Washington Univ School of Medicine St Louis, MO | U | $25,000 | paid | INVESTIGATION OF ROLE OF ATG5 | 201941339349103344 |
| 2018 | National Jewish Health Denver, CO | B | $25,000 | paid | SYSTEMS BIOLOGY OF M. TB | 201941339349103344 |
| 2018 | Albert Einstein College of Medicine Bronx, NY | B | $25,000 | paid | SUFFOCATING M. TUBERCULOSIS | 201941339349103344 |
| 2018 | Health Research Inc Menands, NY | U | $13,750 | paid | WORLD TB DAY | 201941339349103344 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Source filings
Every figure above is traceable to one of these IRS e-file returns by its OBJECT_ID.
| Form | Tax year | Period end | Filed | Schema | IRS OBJECT_ID |
|---|---|---|---|---|---|
| 990PF | 2025 | 2025-12-31 | not stated | 2025v4.1 | 202641289349100719 |
| 990PF | 2024 | 2024-12-31 | not stated | 2024v5.1 | 202501269349100315 |
| 990PF | 2023 | 2023-12-31 | not stated | 2023v5.0 | 202411319349100611 |
| 990PF | 2022 | 2022-12-31 | not stated | 2022v5.0 | 202321239349100617 |
| 990PF | 2021 | 2021-12-31 | not stated | 2021v4.2 | 202211259349101656 |
| 990PF | 2020 | 2020-12-31 | not stated | 2020v4.1 | 202101349349102925 |
| 990PF | 2019 | 2019-12-31 | not stated | 2019v5.1 | 202001349349100045 |
| 990PF | 2018 | 2018-12-31 | not stated | 2018v3.1 | 201941339349103344 |
Derived from IRS Form 990-PF e-file XML; recipient identities from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The same rows as Parquet: manifest; as JSON: /api/funders/141347714.json.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.